Terumo Corporation
IFRS Financial Results for the First Quarter of theFiscal Year Ending March 31, 2019

1IFRS Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2019
August 8, 2018
Exchange where listed: TSE

Name of listed company: TERUMO CORPORATION(URL http://www.terumo.com/): 4543: Shinjiro Sato, President and CEO: Atsuo Omagari, General Manager, Corporate Communication Dept.
: +81 / 3-6742-8550

Company code number
Representative:
Please address all communications toPhone

1. Consolidated Financial Highlights for the Three Months Ended June 30, 2018
(From April 1, 2018 to June 30, 2018)(1) Consolidated operating results(Notes: The amounts shown below ignore values of less than a million yen)

RevenueThree months ended June, 2018
Three months ended June, 2017

Operating profit(Millions of yen)%(Millions of yen)

143,020
139,3122.7－

25,87528,435

Profit before tax% (Millions of yen)

(9.0)
－

23,40628,163

Profit for the period
attributable to theowners of the parent

Profit for the period%(Millions of yen)

(16.9)－

18,05920,310Total comprehensive
income for the period% (Millions of yen)%(Millions of yen)%

18,091
20,336(11.0)－38,534
25,01954.0－(11.1)－Earnings per share,
fully diluted

Earnings per share
(Yen)

(Yen)

Three months ended June, 2018
50.78
47.82
Three months ended June, 2017
57.78
53.96
(Notes)Adjusted operating profit: June 2018: 30,544 million yen June 2017: 32,079 million yen(2) Consolidated financial position
Total assets

As of June 30, 2018
As of March 31, 2018

Equity attributable to theowners of the parent

Net assets

Equity attributable to theowners of the parent ratio(Millions of yen)

(Millions of yen)

(Millions of yen)%

1,093,152
1,078,981

598,530
550,435

598,434
550,30754.7
51.0

2. Dividends
Cash dividends per share
1st quarter2nd quarter3rd quarter

4th quarter

Total

(Yen)

(Yen)

(Yen)

(Yen)

(Yen)

－

23.00

－

27.00

50.00

27.00

－

27.00

54.00

Year ended March, 2018Year ended March, 2019Year ending March, 2019 (forecast)－

3. Consolidated Forecast for the Year Ending March, 2019 (From April 1, 2018 to March 31, 2019)

Revenue(Millions of yen)

Adjusted operating profit%(Millions of yen)

Profit for the year
attributable to the ownersof the parent

Operating profit%(Millions of yen)

282,000(0.9)
55,000(15.2)
Year ending March, 2019
597,000
1.6
122,000(2.3)(Notes)Forecast for fiscal year ending March, 2019 which was announced on May 9, 2018 has been revised.
Assumed exchange rate for fiscal year ending March, 2019: USD1=JPY106, EUR1=JPY130

Half year ending September, 2018

48,000108,000

Earnings per share%(Millions of yen)

%

(Yen)

(16.0)(0.5)

34,50078,500(16.2)(14.0)

96.30
218.52

Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks and uncertainty since these are forecasts on projections made by Terumo based onlimited information available at the moment of disclosure. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results
include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

24. Consolidated Financial Statements① Consolidated Statements of Financial Position
As ofMarch 31, 2018

（Unit: Millions of yen）
As ofJune 30, 2018

AssetsCurrent assets
Cash and cash equivalents

167,832

162,918

Trade and other receivables

121,402

116,172

Other current financial assets

659

473

112,064

120,234

Current tax assets

530

385

Other current assets

8,421

9,310

Total current assets

410,912409,494

Property, plant and equipment

179,196

183,582

Goodwill and intangible assets

442,660

456,123

Inventories

Non-current assets

Investments accounted for using the equity
methodOther non-current financial assets

5,710

5,780

13,815

14,363

Deferred tax assets

23,356

20,722Other non-current assets

3,328

3,085

Total non-current assets

668,068

683,658

1,078,981

1,093,152

Total assets3

（Unit: Millions of yen）
As of
June 30, 2018

As ofMarch 31, 2018
Liabilities and Equity
Liabilities
Current liabilities
Trade and other payables

67,51569,606

Bonds and borrowings

47,43647,737407

679

15,970

5,574

198

162

Other current liabilities

47,48339,331

Total current liabilities

179,013163,092

Bonds and borrowings

288,776

273,356

Other non-current financial liabilities

15,452

13,389Deferred tax liabilities

24,12423,957

Defined benefit liabilities

10,063

10,65482

86

Other non-current liabilities

11,032

10,085

Total non-current liabilities

349,532

331,529

528,545494,621

Share capital

38,716

38,716

Capital surplus

52,44552,344

Treasury stock(101,546)(82,149)

Retained earnings

588,932

597,340

Other components of equity(28,240)(7,817)550,307598,434

12896

550,435

598,530

1,078,981

1,093,152

Other current financial liabilities
Current tax liabilities
Provisions

Non-current liabilities

Provisions

Total liabilities
EquityTotal equity attributable to the owners of theparent
Non-controlling interests
Total equity
Total liabilities and equity

4

② Consolidated Statements of Profit or Loss
For the three months ended
June 30, 2017
139,31263,39875,914
48,7081,413
182
28,435504
640（Unit: Millions of yen）
For the three months ended
June 30, 2018
143,020
63,16279,85754,8101,289
461
25,875
325
2,773

(135)

(20)

28,163
7,853
20,31023,406
5,346
18,059Attributable to:
Owners of the parent
Non-controlling interests
Total profit for the period

20,336(25)
20,31018,091(31)
18,059Earnings per share
Basic earnings per share (yen)Diluted earnings per share (yen)

57.78
53.96

50.78
47.82

Revenue
Cost of sales
Gross profit
Selling, general and administrative expenses
Other income
Other expenses
Operating profit
Finance income
Finance costs
Share of profit (loss) of investments accounted
for using the equity method
Profit before tax
Income tax expenses
Profit for the period

5③ Consolidated Statements of Comprehensive Income

Profit for the period

For the three months ended
June 30, 2017
20,310（Unit: Millions of yen）
For the three months ended
June 30, 201818,059

204

(109)

204

(109)

4,137

20,310

127

177

240

97(0)

－

4,504

20,584

4,708

20,47425,01938,53425,046

38,566(26)(32)

25,01938,534

Other comprehensive income
Items that will not be reclassified to profit or loss
Changes in financial assets measured at fairvalue through other comprehensive income
Total items that will not be reclassified to profit
or loss
Items that are or may be reclassified subsequently toprofit or loss
Exchange differences on translation of foreign
operations
Cash flow hedges
Cost of hedging
Share of other comprehensive income/(loss) ofinvestments accounted for using the equity
methodTotal items that are or may be reclassified
subsequently to profit or loss
Other comprehensive income/(loss) for the period
Total comprehensive income for the period
Attributable toOwners of the parent
Non-controlling interests
Total comprehensive income for the period(Note)

Items in the above statement are net of tax.

6④ Consolidated Statements of Changes in Equity（Unit: Millions of yen）
Equity attributable to the owners of the parent
Other
CapitalTreasury
Retainedcomponents ofsurplus
stock
earnings
equitySharecapitalBalance at April 1, 2017
Profit for the period

38,71652,478(108,225)

513,578－－－

20,336

－

－

－

－

－

－

(5,126) 491,421

101

491,522－

20,336(25)

20,310

－

4,709

4,709

(1)

4,708

－

20,336

4,709

25,046(26)

25,019

－

(0)

－－

(0)

－

(0)

－－

2(1)

(0)

0－

0－

－

－

(7,743)－(7,743)－(7,743)－－－(3)3－－－－－－－－－

136

136－－－－

41

41－

41－

－

1

(7,749)44(7,703)

136(7,567)38,71652,478(108,224)

526,166(372) 508,764

210

508,975

Other comprehensive
incomeTotal comprehensive income
Acquisition of treasury
shares
Disposal of treasury shares
Dividends
Transfer from othercomponents of equity toretained earnings
Change in shares ofsubsidiaries due to capitalincrease
Share-based payments
Total transactions with theowners of the Company
Balance at June 30, 2017

Equity attributable to the owners of the parent
Other
CapitalTreasury
Retainedcomponents ofsurplus
stockearnings
equitySharecapitalBalance at April 1, 2018
Change of the accounting
principles
Balance after the adjustment
Profit for the period
Other comprehensive
incomeTotal comprehensive income
Acquisition of treasury
shares
Disposal of treasury shares
Dividends
Conversion of convertible
bonds
Total transactions with theowners of the Company
Balance at June 30, 2018

Noncontrolling Total equity
interests

Total

38,71652,445(101,546)

588,932－－－54

38,71652,445(101,546)

588,986－－－

18,091－－－－－－

Noncontrolling Total equity
interests

Total(28,240) 550,307

128

550,43554－

54(28,240) 550,361

128

550,490－

18,091(31)

18,059－20,47520,475(0)

20,474－18,091

20,47538,566(32)

38,534

－

(1)

－－

(1)

－

(1)

－

－

75

(23)

(52)

(0)

－

(0)

－－

－

(9,549)－(9,549)－(9,549)－(100)

19,323(164)－

19,057－

19,057－(100)

19,397(9,737)

(52)

9,506

－

9,506

38,71652,344(82,149)

597,340(7,817) 598,434

96

598,530

7－5. Segment information
Reporting segment information
Revenue and operating results of the reporting segments of the Group are described below.
For the first quarter of the fiscal year ended June 30, 2017
（Unit: Millions of yen）

Reportable Segments

Revenue
Revenue from sales toexternal customers
Segment Profit(Adjusted operatingprofit)（Adjustment item）
Amortization ofintangible assets
acquired throughbusiness combinations
Non-recurring profit orloss

Adjustments（Note）

Amountrecorded on
consolidated
financialstatements

CardiacandVascularCompanyGeneral
HospitalCompanyBloodManagementCompany

79,05736,86723,333

139,258

53

139,312

21,154

5,888

3,609

30,652

1,427

32,079(1,645)－(2,162)(3,807)－(3,807)

Total

163

Operating profit

28,435

Finance income

504

Finance costs
Share of profit/(loss) ofinvestment accounted
for using the equity
method(640)

Pre-tax profit

28,163(135)(Note） Amounts in ‘Adjustments’ are as follows:(1) ¥53 million adjustment to revenue from sales to external customers is proceeds from temporary staffing that is
not attributable to reportable segments.
(2) ¥1,427 million adjustment to segment profit consists of ¥166 million for “inventories” and ¥1,261 million for“others”.

8For the first quarter of the fiscal year ended June 30, 2018
（Unit: Millions of yen）
Amountrecordedon
Adjustments
consolidated(Note）
financialstatements

Reportable Segments

Revenue
Revenue from sales
to external customers
Segment Profit(Adjusted operatingprofit)（Adjustment item）
Amortization ofintangible assets
acquired throughbusiness combinations
Non-recurring profit orloss

Cardiac and
VascularCompanyGeneral
HospitalCompanyBloodManagementCompany

79,53538,812

24,595

142,94376

143,020

19,8786,2433,443

29,564979

30,544(1,571)－(2,059)(3,631)(136)(3,767)

Total

(900)

Operating profit

25,875

Finance income

325

Finance costs
Share of profit/(loss) ofinvestment accounted
for using the equity
method(2,773)Pre-tax profit

23,406(20)(Note） Amounts in ‘Adjustments’ are as follows:(1) ¥76 million adjustment to revenue from sales to external customers is mainly proceeds from temporary
staffing that is not attributable to reportable segments.
(2) ¥979 million adjustment to segment profit consists of ¥110 million for “inventories” and ¥868 million for“others”.

9